BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9219830)

  • 1. Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases.
    Mann B; Klussmann E; Vandamme-Feldhaus V; Iwersen M; Hanski ML; Riecken EO; Buhr HJ; Schauer R; Kim YS; Hanski C
    Int J Cancer; 1997 Jul; 72(2):258-64. PubMed ID: 9219830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
    Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
    Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
    Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
    Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adapter protein AP162 connects a sialyl-Le(x)-positive mucin with an apoptotic signal transduction pathway.
    Hartel-Schenk S; Gratchev A; Hanski ML; Ogorek D; Trendelenburg G; Hummel M; Höpfner M; Scherübl H; Zeitz M; Hanski C
    Glycoconj J; 2001; 18(11-12):915-23. PubMed ID: 12820725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression.
    Hanski C; Drechsler K; Hanisch FG; Sheehan J; Manske M; Ogorek D; Klussmann E; Hanski ML; Blank M; Xing PX
    Cancer Res; 1993 Sep; 53(17):4082-8. PubMed ID: 7689422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma.
    Cho M; Dahiya R; Choi SR; Siddiki B; Yeh MM; Sleisenger MH; Kim YS
    Eur J Cancer; 1997 May; 33(6):931-41. PubMed ID: 9291818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
    Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
    Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
    Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
    Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients.
    Grabowski P; Mann B; Mansmann U; Lövin N; Foss HD; Berger G; Scherübl H; Riecken EO; Buhr HJ; Hanski C
    Int J Cancer; 2000 Oct; 88(2):281-6. PubMed ID: 11004681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of sialyl-Le(a)-carrying mucins of human bile; evidence for the presence of MUC1 and MUC3 apoproteins.
    Baeckström D; Karlsson N; Hansson GC
    J Biol Chem; 1994 May; 269(20):14430-7. PubMed ID: 7848403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucins and mucin binding proteins in colorectal cancer.
    Byrd JC; Bresalier RS
    Cancer Metastasis Rev; 2004; 23(1-2):77-99. PubMed ID: 15000151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
    Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
    J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical employer monoclonal antibodies against Le(a), sialyl Le(a), Le(x), and sialyl Le(x) antigens in primary colorectal, carcinomas and lymph node and hepatic lesions.
    Nakagoe T; Fukushima K; Hirota M; Kusano H; Ayabe H; Tomita M; Kamihira S
    J Gastroenterol; 1994 Apr; 29(2):129-38. PubMed ID: 7912139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
    Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
    Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.
    Nakamori S; Ota DM; Cleary KR; Shirotani K; Irimura T
    Gastroenterology; 1994 Feb; 106(2):353-61. PubMed ID: 7905449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation.
    Hanski C; Riede E; Gratchev A; Foss HD; Böhm C; Klussmann E; Hummel M; Mann B; Buhr HJ; Stein H; Kim YS; Gum J; Riecken EO
    Lab Invest; 1997 Dec; 77(6):685-95. PubMed ID: 9426407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
    Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
    World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased methylation of promotor region suppresses expression of MUC2 gene in colon carcinoma cells].
    Riede E; Gratchev A; Foss HD; Mann B; Buhr HJ; Hanski C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):299-302. PubMed ID: 14518264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.